Full Text
Full text is available in PDF
Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Adefovir as a Novel Drug for the Treatment of Chronic Hepatitis B in Patients with End-Stage Renal Disease and Kidney Recipients
Author(s):
1Urology and Nephrology Research Center (UNRC), Shahid Beheshti University, M.C., [email protected], IR-Iran
2Urology and Nephrology Research Center (UNRC), Shahid Beheshti University, M.C., IR-Iran
Published online:Jun 30, 2008
Article type:Review Article
Received:Dec 16, 2007
Accepted:May 20, 2008
How to Cite:Hosseini Moghaddam S, Pour E. Adefovir as a Novel Drug for the Treatment of Chronic Hepatitis B in Patients with End-Stage Renal Disease and Kidney Recipients. Hepat Mon. 2008;8(2):. doi:
Abstract
Copyright
© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 2
Last Update: 1 week ago
- Scopus by Title (Ref): 2
Last Update: 1 week ago
- CrossRef: 0
Last Update: 5 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCCÂ
Search Relations
Related Articles